Medico Remedies Ltd

Medico Remedies Ltd Share Price Today: Live Updates & Key Insights

Get insights on Medico Remedies Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Medico Remedies Ltd Share Price Chart

Medico Remedies Ltd Fundamentals

Traded Volume: 1,41,193

Market Cap(Cr): 422

Avg Traded Price 49.37

1 Year return 13.87%

Upper Circuit 51.5

Lower Circuit 48.4

P/E TTM 37.00

P/B Ratio 1.00

Traded Value(Cr) 71.77

EPS TTM 1.367

Book value 1.367

Dividend 0.00%

Medico Remedies Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Medico Remedies Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Medico Remedies Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -4.44%

1M +6.09%

3M +23.10%

1Y +13.87%

YTD -11.38%

Medico Remedies Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Medico Remedies Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 74396.00

Day Before Yesterday 68438.00

1W Avg 94018.00

1M Avg 2.51L

3M Avg 3.65L

Medico Remedies Ltd Technical Details

Medico Remedies Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 49

Support 2 47

Support 3 46

Pivot Point : 50

Resistance 1 52

Resistance 2 53

Resistance 3 55

Medico Remedies Ltd Corporate Actions

Medico Remedies Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Medico Remedies Ltd’s capital allocation strategies.

All

Ex-Date 16-Mar-2023 Type S Description share@1:5.00 Record Date 16-Mar-2023 Ratio 1:5.00

Ex-Date 16-Nov-2021 Type B Description share@3:1 Record Date 17-Nov-2021 Ratio 3:1

Dividends

No Dividend has been declared by MEDICO

Bonus

Record Date 17-Nov-2021 Ex-Bonus Date 16-Nov-2021 Ratio 3:1

Splits

Record Date 16-Mar-2023 Split Date 16-Mar-2023 Face Value (Before/After) 10.00/2.00

Others

Rights No Rights has been declared by MEDICO

Medico Remedies Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Medico Remedies Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Medico Remedies Ltd's relative performance and valuation against major competitors.

Stock Name Kerala Ayurveda Ltd ₹363.25 (-5.14%) M. Cap (Cr) 4.38 1 Yr Return (%) +16.39% P/E (TTM) -19.19 PB Ratio 10.74

Stock Name SMS Lifesciences India Ltd ₹1437.90 (+6.10%) M. Cap (Cr) 4.35 1 Yr Return (%) +37.68% P/E (TTM) 23.25 PB Ratio 2.32

Stock Name Everest Organics Ltd ₹435.25 (-5.00%) M. Cap (Cr) 4.23 1 Yr Return (%) +199.66% P/E (TTM) 63.90 PB Ratio 10.02

Stock Name Medico Remedies Ltd ₹50.83 (+0.43%) M. Cap (Cr) 4.22 1 Yr Return (%) +13.87% P/E (TTM) 37.17 PB Ratio 6.75

Stock Name Valiant Laboratories Ltd ₹72.99 (-5.21%) M. Cap (Cr) 3.96 1 Yr Return (%) -28.93% P/E (TTM) 78.20 PB Ratio 1.26

Stock Name Bafna Pharmaceuticals Ltd ₹163.74 (-2.00%) M. Cap (Cr) 3.87 1 Yr Return (%) +106.40% P/E (TTM) 44.15 PB Ratio 4.57

Stock Name Zim Laboratories Ltd ₹73.33 (-0.11%) M. Cap (Cr) 3.57 1 Yr Return (%) -28.85% P/E (TTM) 54.38 PB Ratio 1.42

Medico Remedies Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Medico Remedies Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 4.89 Mar 2024 0.00 Mar 2023 8.17 Mar 2022 1.71

PARTICULARS Investing Activities Mar 2025 -3.46 Mar 2024 0.00 Mar 2023 -6.60 Mar 2022 -2.86

PARTICULARS Financing Activities Mar 2025 -0.52 Mar 2024 0.00 Mar 2023 -1.82 Mar 2022 7.40

PARTICULARS Net Cash Flow Mar 2025 0.91 Mar 2024 0.00 Mar 2023 -0.25 Mar 2022 6.25

Medico Remedies Ltd Shareholding Pattern

This shows the ownership breakdown of Medico Remedies Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 61.38%

Public 38.3%

Other Institutions 0.01%

FII 0.3%

Mutual Funds null%

About Medico Remedies Ltd

Medico Remedies Limited was incorporated as a Private Limited Company with the name Medico Remedies Private Limited on March 18, 1994. The status was changed to a Public Limited Company and the Company name was changed to Medico Remedies Limited on March 6, 2017. Medico Remedies is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements. Further in addition to above, the Company also has manufacturing and marketing capabilities in other drugs such as NSAIDS, Antihistaminic, Antidiabetics, Cardio Vascular Drugs, Diuretics, Anti-Epileptics, combination drug kits, syrups and cream & gel for various therapeutic segments.The Company is ISO 9001:2015 certified for its management system for the manufacture and marketing of pharmaceutical products. It also obtained a WHO-GMP accreditation for the manufacture of its products from the World Health Organisation and has also been certified by Government Recognised Star Exports, Pharmacy and Poison Board, NAFDAC and National Drug Authority, Uganda.The Company began its operations in 1994 with manufacturing and servicing of diuretics, anti-malarials, NSAIDS tablets, anti-reterovirals, anti-ulcer drugs and anti-acids tablets. Over the years the company has expanded its scale and scope of operations and currently the Company is engaged in manufacture of formulations for various medicines. As part of this expansion, in year 1999 & 2002, Company has a manufacturing facility for the manufacture of its products located in the State of Maharashtra at Palghar.. The plant is divided into two units, i.e. general formulations unit and beta-lactam unit; the beta lactam unit is further divided into two segments -Penicillin and Cephalosporins.The Company has built a strong relationship with its customers for drug formulations. The clients include Indian as well as foreign pharmaceutical companies like Anphar Limited, Saad Medical, Manfes Pharmaceuticals & Chemical Industries, Award Global Company Limited, Directorate of Health Services (DHS, Maharashtra) to name a few. The Company also earns revenue from the sale of licenses such as FMS license, FPS license and MESI license.In 2018-19, the Company purchased adjoining manufacturing unit with existing factory at Palghar. In January 2018, the Company came up with a Public Issue of 10,99,200 Equity Shares by raising equity capital amounting to Rs 10.99 Crores.

Chairman & Wholetime Director

Haresh Mehta

Registered office 1105/1106 11-Flr Hubtown Solar, N S Phadke Marg Andheri East, Mumbai, Maharashtra, 400069

FAX :91-22-2670 1055/66

Background

Incorporation Year 1994

Face Value ₹2.00

Market Lot 1

Medico Remedies Ltd Latest News

VIEW MORE NEWS

FAQs on Medico Remedies Ltd